EYEN: Volume dana dhuwit perusahaan Eyenovia, Inc.

Simbol resmi perusahaan eyenovia.com (EYEN)

Eyenovia, Inc. is scaling its ophthalmological therapy through partnerships with medical centers, integrating the Optejet system into third-party formulas. The company's cash position illustrates the issuer's financial stability, while the 0.00 mark reflects the latest data. Geopolitical instability is hindering international trials and reagent procurement; however, the commercial launch of micro-dosed spraying is expanding the clinic network, offering patients an alternative to conventional drops.

EYEN - Volume dana dhuwit perusahaan Eyenovia ing rentang 04.07.2022 - 03.07.2025

Rincian analitis lan laporan data perusahaan eyenovia.com (EYEN)

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:Eyenovia, Inc.
Produk merek Eyenovia, Inc.

This metric captures the absolute volume of liquid assets, directly reflecting the business's ability to fund operating activities without external borrowing. This indicator allows for a comparison of real cash reserves against market capitalization to assess the company's intrinsic value. For Eyenovia, Inc. (EYEN), maintaining capital is critical during clinical trials, as the demand for glaucoma treatment remains independent of economic conditions. By analyzing cash and cash equivalents, an investor determines the business's margin of safety. The trend of this indicator demonstrates the burn rate of funds allocated to the development of innovative drug delivery systems.